Envestnet Asset Management Inc. Has $15.54 Million Holdings in Prestige Consumer Healthcare Inc. (NYSE:PBH)

Envestnet Asset Management Inc. lifted its position in Prestige Consumer Healthcare Inc. (NYSE:PBH - Free Report) by 6.4% in the first quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 180,802 shares of the company's stock after buying an additional 10,876 shares during the period. Envestnet Asset Management Inc. owned about 0.36% of Prestige Consumer Healthcare worth $15,544,000 as of its most recent SEC filing.

A number of other large investors have also made changes to their positions in PBH. Franklin Resources Inc. increased its holdings in Prestige Consumer Healthcare by 0.7% during the 4th quarter. Franklin Resources Inc. now owns 21,735 shares of the company's stock worth $1,697,000 after purchasing an additional 150 shares in the last quarter. KBC Group NV increased its holdings in Prestige Consumer Healthcare by 7.4% during the 1st quarter. KBC Group NV now owns 2,199 shares of the company's stock worth $189,000 after purchasing an additional 151 shares in the last quarter. CIBC Private Wealth Group LLC increased its holdings in Prestige Consumer Healthcare by 48.9% during the 4th quarter. CIBC Private Wealth Group LLC now owns 463 shares of the company's stock worth $34,000 after purchasing an additional 152 shares in the last quarter. McIlrath & Eck LLC increased its holdings in Prestige Consumer Healthcare by 19.1% during the 4th quarter. McIlrath & Eck LLC now owns 959 shares of the company's stock worth $75,000 after purchasing an additional 154 shares in the last quarter. Finally, O Shaughnessy Asset Management LLC increased its holdings in Prestige Consumer Healthcare by 3.0% during the 4th quarter. O Shaughnessy Asset Management LLC now owns 7,026 shares of the company's stock worth $549,000 after purchasing an additional 207 shares in the last quarter. Institutional investors own 99.95% of the company's stock.

Wall Street Analyst Weigh In

A number of equities analysts have issued reports on PBH shares. Royal Bank Of Canada upgraded Prestige Consumer Healthcare to a "hold" rating in a report on Thursday, May 8th. Wall Street Zen upgraded shares of Prestige Consumer Healthcare from a "hold" rating to a "buy" rating in a research note on Saturday, July 5th. Three research analysts have rated the stock with a hold rating and four have assigned a buy rating to the company's stock. According to MarketBeat.com, the company presently has an average rating of "Moderate Buy" and a consensus price target of $93.33.

Prestige Consumer Healthcare Stock Up 0.8%

Shares of Prestige Consumer Healthcare stock traded up $0.57 during trading hours on Friday, reaching $75.70. 419,148 shares of the company's stock were exchanged, compared to its average volume of 315,807. The company has a 50 day moving average of $83.16 and a two-hundred day moving average of $82.28. Prestige Consumer Healthcare Inc. has a fifty-two week low of $64.94 and a fifty-two week high of $90.04. The company has a current ratio of 4.20, a quick ratio of 2.82 and a debt-to-equity ratio of 0.55. The stock has a market cap of $3.74 billion, a P/E ratio of 17.65, a P/E/G ratio of 2.25 and a beta of 0.43.

Prestige Consumer Healthcare (NYSE:PBH - Get Free Report) last issued its earnings results on Thursday, May 8th. The company reported $1.32 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.30 by $0.02. Prestige Consumer Healthcare had a net margin of 18.86% and a return on equity of 12.87%. The business had revenue of $296.52 million during the quarter, compared to the consensus estimate of $289.36 million. During the same period last year, the business posted $1.02 EPS. Prestige Consumer Healthcare's revenue was up 7.0% on a year-over-year basis. On average, sell-side analysts forecast that Prestige Consumer Healthcare Inc. will post 4.5 EPS for the current fiscal year.

About Prestige Consumer Healthcare

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.